Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Lote · SciRah

Researcher profile · Semantic Scholar

H. Lote

Share profile

H. Lote — researcher profile on SciRah

h-index: 15
Works: 39
Citations: 2,647

Most-cited papers

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
G. Vlachogiannis, S. Hedayat, A. Vatsiou, Y. Jamin +39 more
2018Science1,886 citations Open access
Semantic Scholar
Longitudinal liquid biopsy and mathematical modelling of clonal evolution forecast waiting time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial
K. Khan, D. Cunningham, B. Werner, G. Vlachogiannis +32 more
2018Cancer Discovery202 citations Open access
Semantic Scholar
PD-1 and PD-L1 blockade in gastrointestinal malignancies.
H. Lote, C. Cafferkey, I. Chau
2015Cancer Treatment Reviews76 citations
Semantic Scholar
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study
K. Khan, M. Rata, D. Cunningham, D. Koh +28 more
2017Gut72 citations Open access
Semantic Scholar
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
F. Sclafani, I. Chau, D. Cunningham, J. Hahne +18 more
2018Scientific Reports57 citations Open access
Semantic Scholar
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial
G. Anandappa, A. Lampis, D. Cunningham, K. Khan +23 more
2019Clinical Cancer Research41 citations Open access
Semantic Scholar
Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era.
G. Gravis, B. Chanez, L. Derosa, B. Beuselinck +17 more
2016Urologic oncology35 citations
Semantic Scholar
Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib.
Y. Thian, A. Gutzeit, D. Koh, R. Fisher +3 more
2014Radiology35 citations
Semantic Scholar
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma
F. Trevisani, M. Ghidini, A. Larcher, A. Lampis +20 more
2016British Journal of Cancer34 citations Open access
Semantic Scholar
Advances in immunotherapy for MMR proficient colorectal cancer.
H. Lote, N. Starling, R. Pihlak, M. Gerlinger
2022Cancer Treatment Reviews29 citations Open access
Semantic Scholar
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer
H. Lote, I. Spiteri, L. Ermini, A. Vatsiou +26 more
2017Annals of Oncology26 citations Open access
Semantic Scholar
Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
H. Lote, Adam Sharp, S. Redana, E. Papadimitraki +2 more
2016Clinics in oncology26 citations
Semantic Scholar
Longitudinal liquid biopsy and mathematical modelling of clonal evolution forecast waiting time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial
K. Khan, D. Cunningham, Benjamin Werner, G. Vlachogiannis +34 more
201917 citations
Semantic Scholar
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
F. Sclafani, I. Chau, D. Cunningham, A. Lampis +18 more
2016Carcinogenesis16 citations Open access
Semantic Scholar
Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
H. Lote, J. Bhosle, K. Thway, K. Newbold +1 more
2014Case Reports in Oncology15 citations Open access
Semantic Scholar
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population.
S. Redana, A. Sharp, H. Lote, K. Mohammed +3 more
2016Breast14 citations Open access
Semantic Scholar
48, XXYY syndrome associated tremor
H. Lote, G. Fuller, P. Bain
2013Practical Neurology14 citations
Semantic Scholar
Introduction of Sprotte needles to a single-centre acute neurology service: before and after study
V. Vakharia, H. Lote
2012JRSM Short Reports11 citations Open access
Semantic Scholar
Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials
H. Lote, I. Chau
2022Expert Opinion on Investigational Drugs10 citations
Semantic Scholar
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
H. Lote, N. Valeri, I. Chau
2018World Journal of Gastrointestinal Oncology10 citations Open access
Semantic Scholar
Adenocarcinoma of the seminal vesicles complicated by antineutrophil cytoplasmic antibody vasculitis: a case report and review of the literature
H. Lote, E. Mannion, T. Cook, T. Cairns +1 more
2013Journal of Medical Case Reports10 citations Open access
Semantic Scholar
Immunotherapy in Gastrointestinal Cancers.
H. Lote, Ian Chau
2024Cancer treatment and research7 citations
Semantic Scholar
Abstract 258: MicroRNAs as biomarkers of resistance to HER2 inhibition in combination with chemotherapy in gastro-esophageal cancer
H. Lote, A. Lampis, G. Vlachogiannis, J. Hahne +11 more
2020Molecular and Cellular Biology / Genetics4 citations
Semantic Scholar
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients
H. Lote, Florentia Mousoullou, G. Vlachogiannis, A. Lampis +13 more
2023Frontiers in Oncology3 citations Open access
Semantic Scholar
Clinical Trials Combining Aromatase Inhibitors with Other Targeted Treatments
H. Lote, S. Johnston
20152 citations
Semantic Scholar
MicroRNAs (miRs) as biomarkers of resistance to trastuzumab in HER2-positive oesophago-gastric cancer: Sub-study within the Planning Treatment for Oesophago-Gastric Cancer—A Randomised Maintenance Therapy Trial (PLATFORM).
H. Lote, Florentia Mousoullou, G. Vlachogiannis, C. Fong +13 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
MicroRNAs as biomarkers of resistance to HER2 inhibitors in combination with chemotherapy in gastro-oesophageal cancer cell lines
H. Lote, D. Zito, R. Burke, E. Smyth +3 more
20161 citations Open access
Semantic Scholar
KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial
F. Sclafani, I. Chau, D. Cunningham, G. Vlachogiannis +16 more
20161 citations Open access
Semantic Scholar
Immuno-Oncology in Pancreatic Ductal Adenocarcinoma: Biological Rationale, Clinical Progress, and Future Directions
A. Lefas, H. Lote, I. Chau
2026Precision Oncology0 citations Open access
Semantic Scholar
Abstract A132: A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy with Modified FOLFIRINOX in Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer
Erin Pierce, Ragnar Bendiksen, Amir Snapir, A. Raufi +3 more
2026Cancer Research0 citations
Semantic Scholar
Exploratory analysis of biomarkers of response to durvalumab in advanced HER2-negative oesophago-gastric adenocarcinoma within a phase 2 clinical trial.
H. Lote, E. Giota, C. Fong, A. Gordon +10 more
2024Journal of Clinical Oncology0 citations Open access
Semantic Scholar
for Identifying
G. Anandappa, A. Lampis, D. Cunningham, H. Khurum +29 more
20190 citations
Semantic Scholar
for Identifying
G. Anandappa, A. Lampis, D. Cunningham, H. Khurum +29 more
20190 citations
Semantic Scholar
Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC)
S. Redana, E. Papadimitraki, K. Mohammed, H. Lote +2 more
20170 citations
Semantic Scholar
Rates of Venous Thromboembolism (VTE) and Other Major Complications During Peri-operative Chemotherapy (CT) for Early Breast Cancer (EBC) in an Off-study Population
S. Redana, A. Sharp, E. Papadimitraki, H. Lote +2 more
20160 citations
Semantic Scholar
Febrile Neutropenia Rates According to BMI and Dose-capping: a Retrospective Analysis in a Tertiary Referral Centre
H. Lote, A. Sharp, S. Redana, E. Papadimitraki +2 more
20160 citations
Semantic Scholar
825PIMPACT ON OVERALL SURVIVAL OF GLANDULAR METASTASIS IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA. ON BEHALF OF THE RENAL CROSS CHANNEL GROUP.
G. Gravis, B. Chanez, L. Derosa, Benoit Beuselinck +16 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
35 Service evaluation: Efficacy and safety of 3rd and 4th line single-agent pemetrexed in the treatment of non-squamous NSCLC
A. Lee, H. Lote, M. O'Brien
20140 citations
Semantic Scholar
a single-centre acute neurology service: before and after study
V. Vakharia, H. Lote
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Valeri×17
Invite
N. Valeri — researcher profile on SciRah
A. Lampis×14
Invite
A. Lampis — researcher profile on SciRah
R. Begum×14
Invite
R. Begum — researcher profile on SciRah
I. Chau×13
Invite
I. Chau — researcher profile on SciRah

×13

Invite

J. Hahne — researcher profile on SciRah

N. Starling×12

Invite

N. Starling — researcher profile on SciRah

Invite

C. Braconi — researcher profile on SciRah

Invite

S. Rao — researcher profile on SciRah

Invite

M. Fassan — researcher profile on SciRah

D. Cunningham×9

Invite

D. Cunningham — researcher profile on SciRah

Invite

D. Watkins — researcher profile on SciRah

Invite

C. Peckitt — researcher profile on SciRah